Akira Yokoyama

Akira Yokoyama

Auto-generated profile, based on publicly available information

Akira Yokoyama

National Hospital Organization Kurihama Medical and Addiction Center Yokosuka Japan

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2009 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
PBPhilip J Brooks
Philip J Brooks
MEMary-Anne Enoch
Mary-Anne Enoch
DGDavid Goldman
David Goldman
TLTing-Kai Li
Ting-Kai Li
AYAkira Yokoyama
Akira Yokoyama
Philip Brooks and colleagues discuss evidence linking the alcohol flushing response (predominantly due to ALDH2 deficiency) with a much higher risk of esophageal cancer from alcohol consumption.

25 August 2008 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
AYAkira Yokoyama
Akira Yokoyama
ETEri Tsutsumi
Eri Tsutsumi
HIHiromi Imazeki
Hiromi Imazeki
YSYoshihide Suwa
Yoshihide Suwa
CNChizu Nakamura
Chizu Nakamura
TYTetsuji Yokoyama
Tetsuji Yokoyama

29 March 2013 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
AYAkira Yokoyama
Akira Yokoyama
TMTakeshi Mizukami
Takeshi Mizukami
TMToshifumi Matsui
Toshifumi Matsui
TYTetsuji Yokoyama
Tetsuji Yokoyama
MKMitsuru Kimura
Mitsuru Kimura
KMKatsuya Maruyama
Katsuya Maruyama

30 April 2007 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
AYAkira Yokoyama
Akira Yokoyama
ETEri Tsutsumi
Eri Tsutsumi
HIHiromi Imazeki
Hiromi Imazeki
YSYoshihide Suwa
Yoshihide Suwa
CNChizu Nakamura
Chizu Nakamura
TYTetsuji Yokoyama
Tetsuji Yokoyama
The less‐active homozygous alcohol dehydrogenase‐1B (ADH1B*1/*1) and inactive heterozygous aldehyde dehydrogenase‐2 (ALDH2*1/*2) increase the risk of upper aerodigestive tract cancer (UADTC) in Japanese alcoholics. We evaluated associations between ADH1B/ALDH2 genotypes and the blood and salivary ethanol/acetaldehyde levels of 80 Japanese alcoholic men in the morning when they first visited our hospital after drinking the day before. Higher levels of ethanol persisted in the blood for longer periods in ADH1B*1/*1 carriers (n = 25) than in ADH1B*2 allele carriers after adjustment for the amount and time of the preceding alcohol consumption and body weight [median (25th–75th %): 20.5 mM (15.5–52.4) vs. below detection level (<DL) (<DL‐6.4), p = 0.0003]. The ethanol levels in blood and saliva were similar, but the acetaldehyde levels in saliva were strikingly higher than in the blood, and were higher in ADH1B*1/*1 carriers than in ADH1B*2 allele carriers [47.4 μM (22.2–87.6) vs. 1.60 (<DL‐26.3) in the saliva, p = 0.009]. The salivary acetaldehyde levels were correlated with salivary acetaldehyde production (r = 0.34, p = 0.002). The oral bacteria and yeast counts were correlated with salivary acetaldehyde production. Both the microorganisms counts and acetaldehyde production decreased after 3 weeks of abstinence, and the decreases were correlated (r = 0.35, p = 0.042). No effect of inactive ALDH2 (n = 12) on ethanol lingering the next morning was observed. In conclusion, the high salivary acetaldehyde levels in the alcoholics were partly attributable to prolonged ethanol exposure because of the less‐active ADH1B and increased salivary acetaldehyde production as a result of oral microorganism overgrowth, and may explain their high risk for UADTC.

1 November 2006 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
AYAkira Yokoyama
Akira Yokoyama
TOTai Omori
Tai Omori
TYTetsuji Yokoyama
Tetsuji Yokoyama
YSYasuo Sato
Yasuo Sato
TMTakeshi Mizukami
Takeshi Mizukami
THToshifumi Hibi
Toshifumi Hibi
Asian case-control studies have shown a strong relationship between the development of squamous cell carcinoma (SCC) of the esophagus and alcohol consumption combined with inactive aldehyde dehydrogenase-2 (ALDH2*1/*2), less-active alcohol dehydrogenase-1B (ADH1B*1/*1), high mean corpuscular volume (MCV), and self-reported facial flushing in response to alcohol. However, little is known about whether these risk factors prospectively influence cancer development in cancer-free alcoholics. Between 1993 and 2005, 808 Japanese alcoholic men diagnosed as cancer-free by an initial endoscopic screening examination received follow-up examinations ranging from 1 to 148 months (median, 31 months) later, and SCC of the upper aerodigestive tract was diagnosed in 53 of them (esophagus in 33 and oropharyngolarynx in 30). Cox proportional hazards analysis showed that the age-adjusted relative hazard for SCC was 11.55 [95% confidence interval (95% CI), 5.73-23.3] in ALDH2*1/*2 heterozygotes compared with ALDH2*1/*1 homozygotes, 2.02 (95% CI, 1.02-4.02) in ADH1B*1/*1 homozygotes compared with ADH1B*1/*2 heterozygotes or *2/*2 homozygotes, 2.64 (95% CI, 1.49-4.67) in patients with flushing compared with those who had never experienced flushing, 2.91 (95% CI, 1.63-5.20) in those with an MCV ≥ 106 compared with those with an MCV < 106, 2.52 (95% CI, 1.22-5.22) in those who smoked ≥30 cigarettes per day compared with those who smoked 0 to 19 cigarettes per day, 7.26 (95% CI, 3.99-13.23) in those with esophageal dysplasia compared with those without distinct iodine-unstained lesions ≥5 mm, and 0.28 (95% CI, 0.09-0.85) in those with body mass index ≥ 23.2 (highest quartile) compared with those with body mass index < 19.0 (lowest quartile). These predictors are useful for selecting appropriately patients for careful follow-up examinations. (Cancer Epidemiol Biomarkers Prev 2006;15(11):2209–15)

13 February 2006 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
AYAkira Yokoyama
Akira Yokoyama
HKHoichi Kato
Hoichi Kato
TYTetsuji Yokoyama
Tetsuji Yokoyama
HIHiroyasu Igaki
Hiroyasu Igaki
TTToshimasa Tsujinaka
Toshimasa Tsujinaka
HWHiroshi Watanabe
Hiroshi Watanabe